EVOLUTIONARY GENOMICS, INC.
company.status.inactiveCIK 884363fmd_0XHM5R1QKX409449K8HVK8JDJ6Services · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Jan 01, 2008 to Dec 31, 2022, 53 periods
Latest annual · FY2020
Millions- Total revenues
- 0
- Operating income
- (2)
- Net income
- (2)
Latest quarter · Q4 FY2022
Millions- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2017 to FY2020
- -27.4%
- Net income, 5 yearsFY2017 to FY2022
- n/m
EVOLUTIONARY GENOMICS, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Operating income | -$2 million | -$2.9 million | 10-K 2023-03-09 · proof | |
| Net income | -$1.9 million | -$2.8 million | 10-K 2023-03-09 · proof | |
| Cash from operating activities | -$640,947 | -$1.6 million | 10-K 2023-03-09 · proof | |
| Total assets | $2.4 million | $2.9 million | -19.7% | 10-K 2023-03-09 · proof |
| Total liabilities | $3.9 million | $3.8 million | +4.2% | 10-K 2023-03-09 · proof |
| Cash and cash equivalents | $577,066 | $214,009 | +169.6% | 10-K 2023-03-09 · proof |
- What was EVOLUTIONARY GENOMICS, INC.'s operating income in fiscal 2022?
- EVOLUTIONARY GENOMICS, INC. reported operating income of -$2 million for fiscal 2022 (the year ended Dec 31, 2022), against -$2.9 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was EVOLUTIONARY GENOMICS, INC.'s net income in fiscal 2022?
- EVOLUTIONARY GENOMICS, INC. reported net income of -$1.9 million for fiscal 2022 (the year ended Dec 31, 2022), against -$2.8 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What was EVOLUTIONARY GENOMICS, INC.'s cash from operating activities in fiscal 2022?
- EVOLUTIONARY GENOMICS, INC. reported cash from operating activities of -$640,947 for fiscal 2022 (the year ended Dec 31, 2022), against -$1.6 million the year before. Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are EVOLUTIONARY GENOMICS, INC.'s total assets?
- As of Dec 31, 2022, EVOLUTIONARY GENOMICS, INC. reported total assets of $2.4 million, against $2.9 million a year earlier (-19.7%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are EVOLUTIONARY GENOMICS, INC.'s total liabilities?
- As of Dec 31, 2022, EVOLUTIONARY GENOMICS, INC. reported total liabilities of $3.9 million, against $3.8 million a year earlier (+4.2%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
- What are EVOLUTIONARY GENOMICS, INC.'s cash and cash equivalents?
- As of Dec 31, 2022, EVOLUTIONARY GENOMICS, INC. reported cash and cash equivalents of $577,066, against $214,009 a year earlier (+169.6%). Source: the 10-K filed with the SEC on Mar 9, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:884363&period_type=annual&limit=5"Information only, not investment advice.